See more : Onamba Co., Ltd. (5816.T) Income Statement Analysis – Financial Results
Complete financial analysis of Adeshwar Meditex Limited (ADESHWAR.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Adeshwar Meditex Limited, a leading company in the Medical – Specialties industry within the Healthcare sector.
- Harrison Vickers and Waterman Inc. (HVCW) Income Statement Analysis – Financial Results
- Gladstone Acquisition Corporation (GLEEU) Income Statement Analysis – Financial Results
- Machhar Industries Limited (MACIND.BO) Income Statement Analysis – Financial Results
- Kina Securities Limited (KSL.AX) Income Statement Analysis – Financial Results
- Marvel Gold Limited (MVL.AX) Income Statement Analysis – Financial Results
Adeshwar Meditex Limited (ADESHWAR.BO)
Industry: Medical - Specialties
Sector: Healthcare
About Adeshwar Meditex Limited
Adeshwar Meditex Ltd. engages in the manufacture of surgical dressings and external preparations products. It offers sterile surgical wound dressing, tulle dressing, medical disposables, adhesive bandages, absorbent gauze, plasters, disinfectants, and medical kits. The company was founded by Mulchand Talati in 1951 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 798.50M | 823.08M | 646.23M | 657.32M | 559.52M | 528.45M | 585.22M |
| Cost of Revenue | 716.08M | 714.22M | 568.03M | 565.12M | 458.19M | 462.88M | 501.47M |
| Gross Profit | 82.42M | 108.86M | 78.21M | 92.21M | 101.33M | 65.57M | 83.74M |
| Gross Profit Ratio | 10.32% | 13.23% | 12.10% | 14.03% | 18.11% | 12.41% | 14.31% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 36.64M | 62.48M | 49.39M | 50.57M | 51.49M | 31.04M | 33.00M |
| Other Expenses | 0.00 | -383.00K | -256.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 36.66M | 62.87M | 49.64M | 50.57M | 51.49M | 31.04M | 33.00M |
| Cost & Expenses | 752.74M | 777.09M | 617.67M | 615.69M | 509.68M | 493.92M | 534.48M |
| Interest Income | 0.00 | 0.00 | 0.00 | 1.57M | 2.17M | 1.44M | 961.00K |
| Interest Expense | 19.23M | 20.50M | 20.26M | 21.87M | 25.19M | 22.29M | 16.65M |
| Depreciation & Amortization | 6.01M | 5.31M | 3.82M | 3.46M | 3.36M | 3.52M | 3.66M |
| EBITDA | 53.31M | 54.48M | 35.84M | 48.73M | 54.84M | 54.49M | 55.19M |
| EBITDA Ratio | 6.68% | 6.23% | 5.01% | 6.86% | 9.51% | 7.20% | 9.30% |
| Operating Income | 44.72M | 45.99M | 28.56M | 41.64M | 49.84M | 34.52M | 50.74M |
| Operating Income Ratio | 5.60% | 5.59% | 4.42% | 6.33% | 8.91% | 6.53% | 8.67% |
| Total Other Income/Expenses | -16.86M | -16.95M | -16.65M | -18.23M | -20.78M | -3.31M | -14.90M |
| Income Before Tax | 27.85M | 29.04M | 11.91M | 23.40M | 29.06M | 31.22M | 35.84M |
| Income Before Tax Ratio | 3.49% | 3.53% | 1.84% | 3.56% | 5.19% | 5.91% | 6.12% |
| Income Tax Expense | 7.77M | 8.30M | 3.98M | 6.63M | 7.90M | 8.71M | 10.23M |
| Net Income | 20.08M | 20.74M | 7.93M | 16.77M | 21.16M | 22.51M | 25.61M |
| Net Income Ratio | 2.51% | 2.52% | 1.23% | 2.55% | 3.78% | 4.26% | 4.38% |
| EPS | 1.39 | 1.44 | 0.55 | 1.59 | 2.05 | 2.26 | 2.96 |
| EPS Diluted | 1.39 | 1.44 | 0.55 | 1.59 | 2.05 | 2.26 | 2.96 |
| Weighted Avg Shares Out | 14.45M | 14.43M | 14.43M | 10.55M | 10.32M | 9.96M | 8.65M |
| Weighted Avg Shares Out (Dil) | 14.43M | 14.43M | 14.43M | 10.53M | 10.30M | 9.96M | 8.65M |
Source: https://incomestatements.info
Category: Stock Reports